Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-059731
Filing Date
2021-10-05
Accepted
2021-10-05 19:53:17
Documents
1
Period of Report
2021-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4085
  Complete submission text file 0001209191-21-059731.txt   5445
Mailing Address C/O TRANSUNION 555 WEST ADAMS STREET CHICAGO IL 60661
Business Address
Hamood Samuel A (Reporting) CIK: 0001645772 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40227 | Film No.: 211308425

Mailing Address 200 INNER BELT ROAD SOMERVILLE MA 02143
Business Address 200 INNER BELT ROAD SOMERVILLE MA 02143 617-229-6499
Finch Therapeutics Group, Inc. (Issuer) CIK: 0001733257 (see all company filings)

IRS No.: 823433558 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)